$21.03
2.41% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$21.03
-0.65 3.00% 1M
+6.42 43.94% 6M
+3.78 21.91% YTD
-6.30 23.05% 1Y
-1.58 6.99% 5Y
+5.09 31.93% 10Y
+5.09 31.93% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.52 2.41%
ISIN
US74340E1038
Symbol
PGNY
Sector
Industry

Key metrics

Market capitalization $1.80b
Enterprise Value $1.55b
P/E (TTM) P/E ratio 36.26
EV/FCF (TTM) EV/FCF 7.90
EV/Sales (TTM) EV/Sales 1.27
P/S ratio (TTM) P/S ratio 1.49
P/B ratio (TTM) P/B ratio 3.86
Revenue growth (TTM) Revenue growth 9.46%
Revenue (TTM) Revenue $1.21b
EBIT (operating result TTM) EBIT $73.10m
Free Cash Flow (TTM) Free Cash Flow $195.78m
Cash position $256.12m
EPS (TTM) EPS $0.58
P/E forward 37.42
P/S forward 1.47
EV/Sales forward 1.26
Short interest 11.16%
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a Progyny Inc forecast:

Buy
40%
Hold
60%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,213 1,213
9% 9%
100%
- Direct Costs 946 946
9% 9%
78%
267 267
10% 10%
22%
- Selling and Administrative Expenses 194 194
9% 9%
16%
- Research and Development Expense - -
-
-
77 77
12% 12%
6%
- Depreciation and Amortization 3.57 3.57
43% 43%
0%
EBIT (Operating Income) EBIT 73 73
11% 11%
6%
Net Profit 53 53
14% 14%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Neutral
GlobeNewsWire
4 days ago
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
Neutral
GlobeNewsWire
16 days ago
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.
Neutral
GlobeNewsWire
about one month ago
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the appointment of Morehouse School of Medicine's Regional Dean for Seattle and Puget Sound's Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fellow o...
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 678
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today